I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| regulatory T cell | 17 studies | 23% ± 8% | |
| CD4-positive, alpha-beta T cell | 16 studies | 21% ± 5% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 14 studies | 23% ± 6% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 9 studies | 23% ± 5% | |
| CD4-positive, alpha-beta memory T cell | 7 studies | 21% ± 4% | |
| mucosal invariant T cell | 6 studies | 19% ± 2% | |
| retinal rod cell | 5 studies | 20% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 17% ± 1% | |
| retinal cone cell | 4 studies | 29% ± 10% | |
| oligodendrocyte precursor cell | 4 studies | 27% ± 8% | |
| oligodendrocyte | 4 studies | 22% ± 4% | |
| endothelial cell | 3 studies | 19% ± 5% | |
| epithelial cell | 3 studies | 31% ± 12% | |
| lymphocyte | 3 studies | 16% ± 1% | |
| GABAergic neuron | 3 studies | 40% ± 9% | |
| glutamatergic neuron | 3 studies | 43% ± 10% | |
| dendritic cell | 3 studies | 29% ± 10% | |
| effector memory CD4-positive, alpha-beta T cell | 3 studies | 28% ± 2% | |
| astrocyte | 3 studies | 25% ± 3% |
